ALDORIL 15 (hydrochlorothiazide; methyldopa) by Merck & Co. is mechanism of action lisinopril inhibits angiotensin-converting enzyme (ace) in human subjects and animals. Approved for hypertension. First approved in 1962.
Drug data last refreshed 12h ago · AI intelligence enriched 1w ago
ALDORIL 15 is a fixed-dose oral combination tablet containing hydrochlorothiazide (a thiazide diuretic) and methyldopa (a centrally-acting antihypertensive agent) approved in 1962 for treatment of hypertension. The product works through dual mechanisms: hydrochlorothiazide increases sodium and chloride excretion to reduce plasma volume, while methyldopa lowers blood pressure through central sympathetic inhibition. This long-established combination is indicated for patients requiring multi-agent antihypertensive therapy.
As a product approaching loss of exclusivity with minimal linked career positions, this asset represents a legacy brand with declining organizational investment and likely reduced team expansion opportunities.
Mechanism of Action Lisinopril inhibits angiotensin-converting enzyme (ACE) in human subjects and animals. ACE is a peptidyl dipeptidase that catalyzes the conversion of angiotensin I to the vasoconstrictor substance, angiotensin II. Angiotensin II also stimulates aldosterone secretion by the…
Worked on ALDORIL 15 at Merck & Co.? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Working on ALDORIL 15 offers limited career advancement opportunity given the product's LOE-approaching lifecycle and minimal linked job count of zero. Career mobility would primarily involve transition to newer assets or portfolio rationalization roles rather than growth-oriented positions.